InvestorsHub Logo
Followers 88
Posts 1170
Boards Moderated 0
Alias Born 09/10/2017

Re: dmb2 post# 448728

Sunday, 03/06/2022 1:13:20 PM

Sunday, March 06, 2022 1:13:20 PM

Post# of 703857
Right dmb, and Linda Powers said as much at a conference back in 2014 or 2015, and I think mentioned Dendreon as an example of why a CDMO. Advent will likely manufacture for other clients at some point and Sawston will become a multi-product facility, but for the time being, I think the current manufacturing suites will be used exclusively for the compassionate use, manual production of DCVax. Advent won’t begin the next phase of expansion at Sawston until DCVax is ready for commercialization, and there’s sufficient funding. The closed automated systems will likely operate in a much less costly class-C environment, while the current higher class-B manufacturing suites may be shared, and only be utilized for a few manual procedures which have not been automated, like the tumor lysate preparations and quality control testing. The gist of my deleted post was that the sub-lease agreement is far from the raw deal that some allege.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News